Form 4 holding
Director
Virpax Pharmaceuticals, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 2,500
- Estimated value
- Report date
- 05 Jul 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount